OTCQB: LXXGF | TSX.V: LXG

  • Company
    • Our Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
    • Join Our Team
    • News Releases
    • In the Media
    • Upcoming Events
  • Investors
    • Presentations
    • Financials
    • Share Structure
    • Stock Information
    • Investor Events
    • Investor Inquiries
  • Markets
    • Biologics Manufacturing
    • Veterinary Diagnostics
  • Products
    • MiQLab® System
    • Assay Panels
    • Request Product Information
    • I’d Like a Demonstration
  • Resources
  • Our Blog
  • Contact
    • Contact
    • Investor Inquiries
    • Support
    • Product Information
    • Subscribe for Updates
Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

Dr. Jack Regan, CEO LexaGene and BioPub Investment Interview – January 26, 2022

by LexaGene | Feb 1, 2022 | Veterinary Diagnostics

Dr. Jack Regan, CEO and Founder of LexaGene gives an update to BioPub Investment group on January 26, 2021.

Dr. Regan with Stock News Now

Dr. Regan with Stock News Now

by LexaGene | Nov 18, 2021 | Investor Information

Dr. Jack Regan discusses scaling MiQLab production and preparing for SNN Network’s Summer Virtual Event, the premier event in MicroCap Finance, with Stock News Now’s CEO Robert Kraft.

LexaGene Talking to Major Players in Plague Detection

LexaGene Talking to Major Players in Plague Detection

by LexaGene | Nov 18, 2021 | Biothreat Detection

The company will be approaching Government and showing the effectiveness and speed of their MiQLab in detecting plague.

COVID Q&A with Infection Control Today

COVID Q&A with Infection Control Today

by LexaGene | Nov 18, 2021 | Human Clinical Diagnostics

Dr. Jack Regan, LexaGene’s CEO gives his perspective on fighting COVID-19 with better diagnostics and automated PCR testing.

MiQLab on Display, Company Highlights Unique Features at WVC Conference in Las Vegas

MiQLab on Display, Company Highlights Unique Features at WVC Conference in Las Vegas

by LexaGene | Nov 18, 2021 | Veterinary Diagnostics

Live from the Floor with Dr. Jack Regan, Founder and CEO.

« Older Entries

Press Releases

  • The Value of a Filter-Based Sample Preparation Cartridge Used in a PCR Device for Sensitive and Rapid Detection of Contaminants February 6, 2023
  • Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology May 25, 2022
  • The Dawn of the Superbugs May 10, 2022
  • LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility April 7, 2022
  • Bacterial Culture: Is It Time to Rethink the Gold Standard? March 28, 2022

Categories

  • Biologics Manufacturing
  • Biothreat Detection
  • Human Clinical Diagnostics
  • Investor Information
  • Product Information
  • Veterinary Diagnostics
  • Contact
  • Support
  • Privacy
  • Terms
  • Site Map

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA
info@lexagene.com | 800.215.1824

Subscribe for Updates
  • Follow
  • Follow
  • Follow
  • Follow

©2022 LexaGene All Rights Reserved